Article
Expression Profiling of Herpesvirus and Vaccinia Virus Proteins Using a High-Throughput Baculovirus Screening System
Affinium Pharmaceuticals.
Present address: Gene Expression & Protein Biochemistry, Bristol-Myers Squibb Company, P.O. Box 4000, Princeton, NJ 08543.
Present address: CanReg Inc., 4 Innovation Drive, Dundas, Ontario Canada L9H 7P3.& Present address: Custom Biologics, 1 Marmac Drive, Toronto, Ontario Canada M9W 1E7.
University of Toronto.
Present address: Research School of Biological Sciences, Sullivan's Creek Road, The Australian National University, ACT Acton 2601 Australia.
Oregon Health Sciences University.
University of Western Ontario.
Present address: Ontario Genomics Institute, 149 College Street, suite 500, Toronto, Ontario Canada M5T1P5.
To whom correspondence should be addressed: lori.frappier@utoronto.ca.
Abstract

We have developed a high-throughput system for generating baculoviruses and testing the expression, solubility, and affinity column purification of encoded proteins. We have used this system to generate baculoviruses for and analyze the expression of 337 proteins from three different herpesviruses (HSV-1, EBV, and CMV) and vaccinia virus. Subsets of these proteins were also tested for expression and solubility in E. coli. Comparisons of the results in the two systems are presented for each virus.
Keywords: baculovirus • high-throughput protein expression • Epstein−Barr virus • herpes simplex virus • cytomegalovirus • vaccinia
View: Full Text HTML | Hi-Res PDF
Tools
-
Add to Favorites
-
Download Citation
-
Email a Colleague -
Permalink
Order Reprints
Rights & Permissions
Citation Alerts
History
- Published In Issue December 12, 2005
- Received May 10, 2005
Cart






